Serum 25-Hydroxyvitamin D levels in subjects with reduced glucose tolerance and type 2 diabetes-The Tromsø OGTT-Study

International Journal for Vitamin and Nutrition Research

Volumn 81, Issue 5, 2011, Pages 317-327

  Hutchinson, Moira S ^a   Figenschau, Yngve ^a   Almås, Bjørg ^b   Njølstad, Inger ^a   Jorde, Rolf ^a,c  

^a UNIVERSITY OF TROMSØ   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Impaired fasting glucose; Impaired glucose tolerance; Insulin resistance; Type 2 diabetes; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; COD LIVER OIL; GLUCOSE; HEMOGLOBIN A1C; INSULIN; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; VITAMIN D;

ADULT; ARTICLE; BODY MASS; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORWAY; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; AGED; BLOOD; COHORT ANALYSIS; DIET RESTRICTION; DIET SUPPLEMENTATION; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; MIDDLE AGED;

AGED; BLOOD GLUCOSE; BODY MASS INDEX; COD LIVER OIL; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; FASTING; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; NORWAY; VITAMIN D;

EID: 84860853512     PISSN: 03009831     EISSN: 16642821     Source Type: Journal    
DOI: 10.1024/0300-9831/a000079     Document Type: Article

References (37)

1. DeLuca, H.F. (2004) Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 80, 1689S-1696S.
2. Norman, A.W. (2006) Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 147,5542-5548.
3. Holick, M.F. (2007) Vitamin D deficiency. N. Engl. J. Med.357, 266-281.
4. Bland., R., Markovic, D., Hills, C.E., Hughes, S.V., Chan, S.L., Squires, P.E. and Hewison, M. (2004) Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. J. Steroid Biochem. Mol. Biol. 89-90, 121-125.
5. Maestro, B., Campion, J., Davila, N. and Calle, C. (2000) Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr. J. 47, 383-391.
6. Clark, S.A., Stumpf, W.E. and Sar, M. (1981) Effect of 1,25 dihydroxyvitamin D3 on insulin secretion. Diabetes 30, 382-386.
7. Nyomba, B.L., Bouillon, R. and De Moor, P. (1984) Influence of vitamin D status on insulin secretion and glucose tolerance in the rabbit. Endocrinology 115, 191-197.
8. Alvarez, J.A. and Ashraf, A. (2010) Role of vitamin d in insulin secretion and insulin sensitivity for glucose homeostasis. Int. J. Endocrinol. 2010, 351385.
9. Gulseth, H.L., Gjelstad, I.M., Tierney, A.C., Lovegrove, J.A., Defoort, C., Blaak, E.E., Lopez-Miranda, J., Kiec-Wilk, B., Risérus, U., Roche, H.M., Drevon, C.A. and Birkeland, K.I. (2010) Serum vitamin D concentration does not predict insulin action or secretion in European subjects with the metabolic syndrome. Diabetes Care 33, 923-925.
10. Manco, M., Calvani, M., Nanni, G., Greco, A.V., Iaconelli, A., Gasbarrini, G., Castagneto, M. and Mingrone, G. (2005) Low 25-hydroxyvitamin D does not affect insulin sensitivity in obesity after bariatric surgery. Obes. Res. 13, 1692-1700.
11. Ford, E.S., Zhao, G., Tsai, J. and Li, C. (2011) Associations Between Concentrations of Vitamin D and Concentrations of Insulin, Glucose, and HbA1c Among Adolescents in the United States. Diabetes Care 34, 646-648.
12. Del Gobbo, L.C., Song, Y., Dannenbaum, D.A., Dewailly, E. and Egeland, G.M. (2011) Serum 25-Hydroxyvitamin D Is not Associated with Insulin Resistance or Beta Cell Function in Canadian Cree. J. Nutr. 141, 290-295.
13. Forde, O.H. and Thelle, D.S. (1977) The Tromso heart study: risk factors for coronary heart disease related to the occurrence of myocardial infarction in first degree relatives. Am. J. Epidemiol. 105, 192-199.
14. Kamycheva, E., Jorde, R., Figenschau, Y. and Haug, E. (2007) Insulin sensitivity in subjects with secondary hyperparathyroidism and the effect of a low serum 25-hydroxyvitamin D level on insulin sensitivity. J. Endocrinol. Invest. 30, 126-132.
15. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. and Turner, R.C. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-9.
16. Katz, A., Nambi, S.S., Mather, K., Baron, A.D., Follmann, D.A., Sullivan, G. and Quon, M.J. (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J. Clin. Endocrinol. Metab. 85, 2402-10.
17. Gutt, M., Davis, C.L., Spitzer, S.B., Llabre, M.M., Kumar, M., Czarnecki, E.M., Schneiderman, N., Skyler, J.S. and Marks, J.B. (2000) Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures. Diabetes Res. Clin. Pract. 47, 177-184.
18. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. (1999) Part 1: Diagnosis and Classification of Diabetes Mellitus. World Health Org., Geneva.
19. Genuth, S., Alberti, K.G., Bennett, P., Buse, J., Defronzo, R., Kahn, R., Kitzmiller, J., Knowler, W.C., Lebovitz, H., Lernmark, A., Nathan, D., Palmer, J., Rizza, R., Saudek, C., Shaw, J., Steffes, M., Stern, M., Tuomilehto, J. and Zimmet, P. (2003) Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26, 3160-3167.
20. Faerch, K., Borch-Johnsen, K., Holst, J.J. and Vaag, A. (2009) Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes? Diabetologia 52, 1714-1723.
21. Jorde, R., Sneve, M., Emaus, N., Figenschau, Y. and Grimnes, G. (2010) Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromsø study. Eur. J. Nutr. 49, 401-407.
22. Wang, T.J., Zhang, F., Richards, J.B., Kestenbaum, B., van Meurs, J.B., Berry, D., Kiel, D.P. et al. (2010) Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376, 180-188.
23. Ramos-Lopez, E., Kahles, H., Weber, S., Kukic, A., Penna-Martinez, M., Badenhoop, K. and Louwen, F. (2008) Gestational diabetes mellitus and vitamin D deficiency: genetic contribution of CYP27B1 and CYP2R1 polymorphisms. Diabetes Obes. Metab. 10, 683-685.
24. Szoke, E. and Gerich, J.E. (2005) Role of impaired insulin secretion and insulin resistance in the pathogenesis of type 2 diabetes mellitus. Compr. Ther. 31, 106-112.
25. Abdul-Ghani, M.A., Tripathy, D. and DeFronzo, R.A. (2006) Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29, 1130-1139.
26. Hanefeld, M., Koehler, C., Fuecker, K., Henkel, E., Schaper, F. and Temelkova-Kurktschiev, T. (2003) Impaired Glucose Tolerance for Atherosclerosis and Diabetes study. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study. Diabetes Care 26, 868-874.
27. Baynes, K.C., Boucher, B.J., Feskens, E.J. and Kromhout, D. (1997) Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia 40, 344-347.
28. Chiu, K.C., Chu, A., Go, V.L. and Saad, M.F. (2004) Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am. J. Clin. Nutr. 79, 820-825.
29. Boucher, B.J., Mannan, N., Noonan, K., Hales, C.N. and Evans, S.J. (1995) Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia 38, 1239-1245.
30. Bischoff-Ferrari, H.A., Giovannucci, E., Willett, W.C., Dietrich, T. and Dawson-Hughes, B. (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am. J. Clin. Nutr. 84, 18-28.
31. von Hurst, P.R., Stonehouse, W. and Coad, J. (2010) Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-a randomised, placebo-controlled trial. Br. J. Nutr. 103, 549-555.
32. Johnson, J.A., Grande, J.P., Roche, P.C. and Kumar, R. (1994) Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas. Am. J. Physiol. 267, E356-E360.
33. Fraser, A., Williams, D. and Lawlor, D.A. (2010) Associations of serum 25-hydroxyvitamin D, parathyroid hormone and calcium with cardiovascular risk factors: analysis of 3 NHANES cycles (2001-2006). PLoS One 5, e13882.
34. Williams, D.M., Fraser, A. and Lawlor, D.A. (2011) Associations of vitamin D, parathyroid hormone and calcium with cardiovascular risk factors in US adolescents. Heart 97, 315-320.
35. Kamycheva, E., Sundsfjord, J. and Jorde, R. (2004) Serum parathyroid hormone levels predict coronary heart disease: the Tromsø Study. Eur. J. Cardiovasc. Prev. Rehabil. 11, 69-74.
36. Jorde, R., Sneve, M., Torjesen, P. and Figenschau, Y. (2010) No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J. Intern. Med. 267, 462-472.
37. Grimnes, G., Almaas, B., Eggen, A.E., Emaus, N., Figenschau, Y., Hopstock, L.A., Hutchinson, M.S., Methlie, P., Mihailova, A., Sneve, M., Torjesen, P., Wilsgaard, T. and Jorde, R. (2010) Effect of smoking on the serum levels of 25-hydroxyvitamin D depends on the assay employed. Eur. J. Endocrinol. 163, 339-348.